Actigraphy was also used to determine sleep onset. The placebo group showed no change on any of the measured parameters. There was no significant effect on sustained attention time, as measured by the Bourdon-Vos test. Five of the treated children reported side effects during the first two days of melatonin treatment, including headache, dizziness, and malaise. Dr. Smits noted that while the study included 38 children with attention-deficit hyperactivity disorder, the results of the study were independent of this diagnosis, and remained unchanged when analysis without this subgroup was conducted.
Sleep improves without affecting daytime sustained attention.
Any question regarding a medical diagnosis, treatment, referral, drug availability or pricing should be directed to either a licensed physician or to the product's manufacturer. All rights reserved.